Your browser doesn't support javascript.
loading
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.
Lassman, Andrew B; Wen, Patrick Y; van den Bent, Martin J; Plotkin, Scott R; Walenkamp, Annemiek M E; Green, Adam L; Li, Kai; Walker, Christopher J; Chang, Hua; Tamir, Sharon; Henegar, Leah; Shen, Yao; Alvarez, Mariano J; Califano, Andrea; Landesman, Yosef; Kauffman, Michael G; Shacham, Sharon; Mau-Sørensen, Morten.
Afiliação
  • Lassman AB; Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, New York, New York. ABL7@cumc.columbia.edu.
  • Wen PY; Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, New York, New York.
  • van den Bent MJ; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Plotkin SR; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Walenkamp AME; Cancer Center and Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
  • Green AL; University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Li K; Morgan Adams Foundation Pediatric Brain Tumor Research Program, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado.
  • Walker CJ; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Chang H; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Tamir S; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Henegar L; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Shen Y; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Alvarez MJ; DarwinHealth Inc, New York, New York.
  • Califano A; DarwinHealth Inc, New York, New York.
  • Landesman Y; Department of Systems Biology, Columbia University, New York, New York.
  • Kauffman MG; Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, New York, New York.
  • Shacham S; Department of Systems Biology, Columbia University, New York, New York.
  • Mau-Sørensen M; Department of Biomedical Informatics, Columbia University, New York, New York.
Clin Cancer Res ; 28(3): 452-460, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34728525
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Neoplasias Encefálicas / Glioblastoma / Hidrazinas / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Neoplasias Encefálicas / Glioblastoma / Hidrazinas / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2022 Tipo de documento: Article